TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

Active, not recruitingOBSERVATIONAL
Enrollment

814

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Non-small Cell Lung Cancer
Trial Locations (18)

CM20 1QX

The Princess Alexandra Hospital NHS Trust, Harlow

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

NW1 2PG

University College London Hospitals NHS Foundation Trust, London

KT16 0PZ

Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey

AB15 6RE

Grampian Health Board, Aberdeen

B9 5SS

Heart of England NHS Foundation Trust, Birmingham

CF14 4XW

Cardiff and Vale University Health Board, Cardiff

Unknown

NHS Greater Glasgow & Clyde, Glasgow

Liverpool Heart and Chest Hospital, Liverpool

LE1 5WW

University Hospitals of Leicester NHS Trust, Leicester

E1 1RD

Barts Health NHS Trust, London

N18 1QX

North Middlesex University Hospital NHS Trust, London

N19 5NF

The Whittington Hospital NHS Trust, trading as Whittington Health, London

NW3 2QG

Royal Free Hospital, London

Royal Free London NHS Foundation Trust - Barnet Hospital, London

SW3 6NP

Royal Brompton & Harefield NHS Foundation Trust, London

M23 9LT

University Hospital of South Manchester NHS Foundation Trust, Manchester

S5 7AU

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

University College, London

OTHER

NCT01888601 - TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx) | Biotech Hunter | Biotech Hunter